Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
20–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patient with histologically- or cytologically-confirmed colorectal adenocarcinoma with unresectable or metastatic disease documented on diagnostic imaging studies.
Patient must have at least one RECIST-defined measurable lesion that has not been treated with prior local therapy.
You may not be if
History of another primary malignancy within 3 years prior to study entry, with the exception of non-melanoma skin cancer and in situ carcinoma of the uterine cervix.
Current, recent, or planned participation in an experimental treatment drug study other than this protocol.
Clareo Health | Study Of Sunitinib With FOLFIRI In Colorectal Cancer
